Глобальная карта > Инновации > North America and Caribbean > United States > Wakefield > Innovation Pharmaceuticals
Innovation Pharmaceuticals icon
Innovation Pharmaceuticals and George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID) have completed extensive pre-clinical laboratory testing demonstrating the potent anti-SARS-CoV-2 activity of Brilacidin, a defensin-mimetic drug candidate, which is being developed as a potential COVID-19 treatment.
Rankings by SemRush
Национальный рейтинг
352nd
in United States
Региональный рейтинг
398th
in North America and Caribbean
Глобальный рейтинг
956th
worldwide
Loading startups...